These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7284686)
41. Routine use of hyoscine N butylbromide (Buscopan) in double contrast barium enema examinations. Lee JR Clin Radiol; 1982 May; 33(3):273-6. PubMed ID: 7075130 [TBL] [Abstract][Full Text] [Related]
42. Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Bassotti G; Imbimbo BP; Gaburri M; Daniotti S; Morelli A Digestion; 1987; 37(1):59-64. PubMed ID: 3609506 [TBL] [Abstract][Full Text] [Related]
43. Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. De Conno F; Caraceni A; Zecca E; Spoldi E; Ventafridda V J Pain Symptom Manage; 1991 Nov; 6(8):484-6. PubMed ID: 1720156 [TBL] [Abstract][Full Text] [Related]
44. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)]. HEINKEL K Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696 [No Abstract] [Full Text] [Related]
45. [Clinical contribution to the study of hyoscine N-butylbromide (B 2011)]. FORET J; SIMILON A J Belge Urol; 1952 Dec; 21(2):55-8. PubMed ID: 13044763 [No Abstract] [Full Text] [Related]
46. [The treatment of spastic states with hyoscine-N-butylbromide]. HARTMANN HG Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960 [No Abstract] [Full Text] [Related]
47. The influence of spasmolytic agents on heart rate variability and gastrointestinal motility in normal horses. Sundra TM; Harrison JL; Lester GD; Raidal SL; Phillips JK Res Vet Sci; 2012 Dec; 93(3):1426-33. PubMed ID: 22683390 [TBL] [Abstract][Full Text] [Related]
48. Hyoscine butylbromide to relieve utero-tubal obstruction at hysterosalpingography. Alper MM; Garner PR; Spence JE Br J Radiol; 1985 Sep; 58(693):915. PubMed ID: 3842296 [No Abstract] [Full Text] [Related]
49. [Eosphagomanometric finding in man after intravenous administration of a new cholinolytic (pramiverine), atropine and scopolamine butylbromide]. Niemann H; Jakob G Arzneimittelforschung; 1976 Apr; 26(4b):728-30. PubMed ID: 989022 [TBL] [Abstract][Full Text] [Related]
50. Assessment of potential selectivity of antispasmodics for the various sections of the gastrointestinal tract of the rat as a guideline for their clinical use. Maggi CA; Meli A Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):221-31. PubMed ID: 6135399 [TBL] [Abstract][Full Text] [Related]
51. Angioneurotic oedema and urticaria induced by hyoscine butylbromide. Robinson AC; Teeling M Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123 [TBL] [Abstract][Full Text] [Related]
53. [Effects of trimebutine maleate on interdigestive motility of the stomach and small intestine in conscious dogs]. Yamada K; Iizuka M; Takaiti O Nihon Heikatsukin Gakkai Zasshi; 1982 Mar; 18(1):45-55. PubMed ID: 7143841 [TBL] [Abstract][Full Text] [Related]
54. Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Taylor SA; Halligan S; Goh V; Morley S; Bassett P; Atkin W; Bartram CI Radiology; 2003 Oct; 229(1):99-108. PubMed ID: 12944595 [TBL] [Abstract][Full Text] [Related]
55. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants]. GADEKE R Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076 [No Abstract] [Full Text] [Related]
56. Electrical and mechanical effects of hyoscine butylbromide on the human stomach: a non-invasive approach. Américo MF; Miranda JR; Corá LA; Romeiro FG Physiol Meas; 2009 Apr; 30(4):363-70. PubMed ID: 19282558 [TBL] [Abstract][Full Text] [Related]
57. [Labor: possibility of modifying its course by means of administration of drugs with spasmolytic action]. Winkler S; Sparpaglione G; Rella R Minerva Ginecol; 1979 Jun; 31(6):455-60. PubMed ID: 40167 [No Abstract] [Full Text] [Related]
58. [Scopolamine-N-butyl bromide loaded cystometry and its clinical significance]. Sugiyama T; Esa A; Park YC; Kaneko S; Kurita T Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):720-5. PubMed ID: 3669479 [No Abstract] [Full Text] [Related]
59. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog. Sasaki D; Kido A; Yoshida Y Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):333-7. PubMed ID: 6147311 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of bile salt excretion and bile flow by spasmolytic drugs. An additional therapeutic effect in the treatment of biliary colics? Klapdor R; Sepehr H Arzneimittelforschung; 1978; 28(1):46-8. PubMed ID: 580197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]